PhaseBio Pharmaceuticals Inc. (PHAS) jumped 14.55% or 0.47 to $3.7. It is about 25044 shares traded, which is 52.15% compare to the average total volume 48020. The market cap of PHAS is $90.64 million. The year to date change is 17.58%. The 52 week price range is from $2.55 to $6.0. Price of PHAS have changed 5.90% during last week. It have changed -1.52% over last month, -35.40% over last 3 months, -35.40% over last 6 months and -35.40% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PHAS is 3.93. It is 6.22% above current price. The 52-week High is 6.0. It is 62.16% from the current price. The 52-week Low is 2.55. It is -31.08% from current price.
There are some statistics of PHAS. It is has market cap $90.64 million. The share outstanding is 24.50 million. The average volume is 48020. The percent of top 15 Institution holding is 3.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PHAS is 17.05%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PHAS is -72.08%.